MedPath

Autoimmunity in Retinitis Pigmentosa

Not Applicable
Conditions
Retinitis Pigmentosa
Registration Number
NCT00433277
Lead Sponsor
Semmelweis University
Brief Summary

Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Clinical diagnosis of retinitis pigmentosa
Exclusion Criteria
  • Cataract
  • Extremely low ERG wave amplitude (less than 8% of normal)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Semmelweis University, Dept. of Ophthalmology

🇭🇺

Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath